Global Transplant Drug Monitoring Assay Market Report

Description

List of Tables

The global demand for Transplant Drug Monitoring Assay Market is presumed to reach the market size of nearly USD 645.2 MN by 2030 from USD 212.72 MN in 2022 with a CAGR of 13.12% under the study period 2023 - 2030.

Transplant drug monitoring assay is crucial in helping health care professionals maintain plasma and blood levels of immunosuppressants within their respective therapeutic ranges. Transplant drug monitoring assay starts with the initiation of medication. It includes the determination of a preliminary dosage regimen acceptable for the patient and clinical state characteristics such as age, body mass index, weight, organ function and drug therapy.

MARKET DYNAMICS:

The factors fueling the market growth are the increased demand for organ transplants, increased R&D funding, and an increase in the prevalence of chronic diseases such as kidney diseases. Moreover, an increase in the need for point-of-care therapeutic drug monitoring and home-based therapeutic drug monitoring is likely to offer lucrative market opportunities for players operating in the global transplant drug monitoring assay industry during the forecast period. Additionally, a rise in healthcare expenditure, improvement in healthcare infrastructure, increase in global per capita income, and government reimbursement programs are projected to present profitable prospects in the transplant drug monitoring assay market in the upcoming years. However, the need for huge investments and the reluctance of small hospitals to offer transplant drug monitoring assay services may hamper the market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of transplant drug monitoring assay. The growth and trends of transplant drug monitoring assay industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the transplant drug monitoring assay market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

Equipment
Consumables (Chromatography & Ms Detectors, Immunoassay Analyzers, Clinical Chemistry Analyzers)

By Technology

Chromatography-Ms
Immunoassays

By Drug

Tacrolimus
Methotrexate
Cyclosporin
Others

By End-User

Hospital Laboratories
Commercial & Private Laboratories
Others

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Transplant Drug Monitoring Assay market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Transplant Drug Monitoring Assay market include Abbott, Thermo Fisher Scientific Inc., H.U. Group Holdings Inc. (Fujirebio Holdings, Inc.), Hoffmann-La Roche Ltd., Siemens Healthineers AG, Hologic Inc., Danaher Corporation, Bio-Rad Laboratories Inc., Other prominent players. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR11218699

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . TRANSPLANT DRUG MONITORING ASSAY - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By Technology
- 3.7.3 Market Attractiveness Analysis By Drug
- 3.7.4 Market Attractiveness Analysis By End-user
- 3.7.5 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL TRANSPLANT DRUG MONITORING ASSAY MARKET ANALYSIS BY PRODUCT

6.1 Overview by Product
6.2 Historical and Forecast Data
6.3 Analysis by Product
6.4 Equipment Historic and Forecast Sales by Regions
6.5 Consumables (Chromatography & MS Detectors, Immunoassay Analyzers, Clinical Chemistry Analyzers) Historic and Forecast Sales by Regions

7 . GLOBAL TRANSPLANT DRUG MONITORING ASSAY MARKET ANALYSIS BY TECHNOLOGY

7.1 Overview by Technology
7.2 Historical and Forecast Data
7.3 Analysis by Technology
7.4 Chromatography-MS Historic and Forecast Sales by Regions
7.5 Immunoassays Historic and Forecast Sales by Regions

8 . GLOBAL TRANSPLANT DRUG MONITORING ASSAY MARKET ANALYSIS BY DRUG

8.1 Overview by Drug
8.2 Historical and Forecast Data
8.3 Analysis by Drug
8.4 Tacrolimus Historic and Forecast Sales by Regions
8.5 Methotrexate Historic and Forecast Sales by Regions
8.6 Cyclosporin Historic and Forecast Sales by Regions
8.7 Others Historic and Forecast Sales by Regions

9 . GLOBAL TRANSPLANT DRUG MONITORING ASSAY MARKET ANALYSIS BY END-USER

9.1 Overview by End-user
9.2 Historical and Forecast Data
9.3 Analysis by End-user
9.4 Hospital Laboratories Historic and Forecast Sales by Regions
9.5 Commercial & Private Laboratories Historic and Forecast Sales by Regions
9.6 Others Historic and Forecast Sales by Regions

10 . GLOBAL TRANSPLANT DRUG MONITORING ASSAY MARKET ANALYSIS BY GEOGRAPHY

10.1. Regional Outlook
10.2. Introduction
10.3. North America Sales Analysis
- 10.3.1. Overview, Historic and Forecast Sales Analysis
- 10.3.2. North America By Segment Sales Analysis
- 10.3.3. North America By Country Sales Analysis
- 10.3.4. United State Sales Analysis
- 10.3.5. Canada Sales Analysis
- 10.3.6. Mexico Sales Analysis
10.4. Europe Sales Analysis
- 10.4.1. Overview, Historic and Forecast Sales Analysis
- 10.4.2. Europe by Segment Sales Analysis
- 10.4.3. Europe by Country Sales Analysis
- 10.4.4. United Kingdom Sales Analysis
- 10.4.5. France Sales Analysis
- 10.4.6. Germany Sales Analysis
- 10.4.7. Italy Sales Analysis
- 10.4.8. Russia Sales Analysis
- 10.4.9. Rest Of Europe Sales Analysis
10.5. Asia Pacific Sales Analysis
- 10.5.1. Overview, Historic and Forecast Sales Analysis
- 10.5.2. Asia Pacific by Segment Sales Analysis
- 10.5.3. Asia Pacific by Country Sales Analysis
- 10.5.4. China Sales Analysis
- 10.5.5. India Sales Analysis
- 10.5.6. Japan Sales Analysis
- 10.5.7. South Korea Sales Analysis
- 10.5.8. Australia Sales Analysis
- 10.5.9. Rest Of Asia Pacific Sales Analysis
10.6. Latin America Sales Analysis
- 10.6.1. Overview, Historic and Forecast Sales Analysis
- 10.6.2. Latin America by Segment Sales Analysis
- 10.6.3. Latin America by Country Sales Analysis
- 10.6.4. Brazil Sales Analysis
- 10.6.5. Argentina Sales Analysis
- 10.6.6. Peru Sales Analysis
- 10.6.7. Chile Sales Analysis
- 10.6.8. Rest of Latin America Sales Analysis
10.7. Middle East & Africa Sales Analysis
- 10.7.1. Overview, Historic and Forecast Sales Analysis
- 10.7.2. Middle East & Africa by Segment Sales Analysis
- 10.7.3. Middle East & Africa by Country Sales Analysis
- 10.7.4. Saudi Arabia Sales Analysis
- 10.7.5. UAE Sales Analysis
- 10.7.6. Israel Sales Analysis
- 10.7.7. South Africa Sales Analysis
- 10.7.8. Rest Of Middle East And Africa Sales Analysis

11 . COMPETITIVE LANDSCAPE OF THE TRANSPLANT DRUG MONITORING ASSAY COMPANIES

11.1. Transplant Drug Monitoring Assay Market Competition
11.2. Partnership/Collaboration/Agreement
11.3. Merger And Acquisitions
11.4. New Product Launch
11.5. Other Developments

12 . COMPANY PROFILES OF TRANSPLANT DRUG MONITORING ASSAY INDUSTRY

12.1. Top Company Share Analysis
12.2. Market Concentration Rate
12.3. Abbott
- 12.3.1. Company Overview
- 12.3.2. Company Revenue
- 12.3.3. Products
- 12.3.4. Recent Developments
12.4. Thermo Fisher Scientific Inc.
- 12.4.1. Company Overview
- 12.4.2. Company Revenue
- 12.4.3. Products
- 12.4.4. Recent Developments
12.5. H.U. Group Holdings Inc.
- 12.5.1. Company Overview
- 12.5.2. Company Revenue
- 12.5.3. Products
- 12.5.4. Recent Developments
12.6. Fujirebio Holdings Inc.
- 12.6.1. Company Overview
- 12.6.2. Company Revenue
- 12.6.3. Products
- 12.6.4. Recent Developments
12.7. Hoffmann-La Roche Ltd.
- 12.7.1. Company Overview
- 12.7.2. Company Revenue
- 12.7.3. Products
- 12.7.4. Recent Developments
12.8. Siemens Healthineers AG
- 12.8.1. Company Overview
- 12.8.2. Company Revenue
- 12.8.3. Products
- 12.8.4. Recent Developments
12.9. Hologic Inc.
- 12.9.1. Company Overview
- 12.9.2. Company Revenue
- 12.9.3. Products
- 12.9.4. Recent Developments
12.10. Danaher Corporation
- 12.10.1. Company Overview
- 12.10.2. Company Revenue
- 12.10.3. Products
- 12.10.4. Recent Developments
12.11. Bio-Rad Laboratories Inc.
- 12.11.1. Company Overview
- 12.11.2. Company Revenue
- 12.11.3. Products
- 12.11.4. Recent Developments
12.12. Other Prominent Players
- 12.12.1. Company Overview
- 12.12.2. Company Revenue
- 12.12.3. Products
- 12.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies